SNP Typing of Mycobacterium leprae Clinical Strains in Côte d'Ivoire Reveals Genotype 4 Circulating

Amon Aby Christiane^{1, 2,} , Coulibaly N’Golo David¹, Dehe Bahou Roger^{1, 2}, Kouakou Henry³, Kakou-N’Gazoa Solange¹, Djaman Allico Joseph^{1, 2}, Bamba Vagamon³ and Dosso Mireille¹

¹Molecular Biology Platform, Pasteur Institute of Côte d'Ivoire, BP 490 Abidjan, Abidjan, Côte d’Ivoire

²UFR Biosciences, Laboratory of biology and health, Felix Houphouet- Boigny University, Abidjan, Côte d’Ivoire

³Follereau Raoul Institute of Côte d’Ivoire, Adzope, Côte d’Ivoire

Cite this paper:
Amon Aby Christiane, Coulibaly N’Golo David, Dehe Bahou Roger, Kouakou Henry, Kakou-N’Gazoa Solange, Djaman Allico Joseph, Bamba Vagamon and Dosso Mireille. SNP Typing of Mycobacterium leprae Clinical Strains in Côte d'Ivoire Reveals Genotype 4 Circulating. American Journal of Biomedical Research. 2021; 9(2):30-35. doi: 10.12691/ajbr-9-2-2

Abstract

Despite years of chemotherapy and the consequent reduction in the prevalence of leprosy in Côte d'Ivoire, there are still high levels of new detection cases. Thus the slow onset of leprosy and the reliance on physical examination for detection of the disease have limited the epidemiological follow-up necessary to understand and control transmission. The differentiation of isolates of Mycobacterium leprae, the causative organism of leprosy, has not yet been established in Côte d'Ivoire. Three SNP loci have been found informative and have been used to understand the evolution and global spread of M. leprae. Based on these reports and the availability of the whole genome sequence, a SNP analysis for strain typing has been realized. This preliminary study present the results of the M. leprae genotype study circulating in Côte d'Ivoire. For each clinically confirmed case of multibacillary leprosy (new cases or relapses), a sample of dermal juice was examined after Ziehl-Neelsen staining and a specific PCR targeting the RLEP repeat sequence. 31 isolates were used to search for single nucleotide polymorphism (SNP) present in the M. leprae genome at positions 14676, 1642875 and 2935685, then determined after sequencing of the mutation zones. The SNPs were determined with a yield of 44,92% (31/69). Genotype 4 was the only genotype founded from the 31 strains identified. This genotype corresponds to those previously reported as widespread in West African countries including Côte d'Ivoire.

Keywords:
M. leprae single nucleotide polymorphism (SNP) genotyping Côte d'Ivoire

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

References:

[1]	WHO, Global leprosy update; reducing disease burden. W E R, 89 (36). 389-400. 2014.
[2]	WHO, Status of leprosy in the world: need for early case detection. W E R, 90. 461-474. 2018.
[3]	Blok, D, S. de Vlas, A. Geluk, Richardus J, Minimum requirements and optimal testing strategies of a diagnostic test for leprosy as a tool towards zero transmission: A modeling study. PLoS Negl Trop Dis 12 (5). e0006529.2018.
[4]	Liu, H, Discovery of six new susceptibility loci and analysis of pleiotropic effectsin leprosy. Nat genet 47, 267-271. 2015.
[5]	Hagge, D, Opening a Can of Worms: Leprosy Reactions and Complicit Soil-Transmitted Helminths. EBio Medicine 23, 119-124. 2017.
[6]	Truman, R, Singh, P, Sharma, R., Busso, P., Rougemont, J., Paniz-Mondolfi, A, Kapopoulou, A., Brisse, S., Scollard, D., Gillis,T., and Cole S, Probable Zoonotic Leprosy in the Southern United States, N Engl J Med 364, 1626-1633. 2011.
[7]	Singh, P, and Cole S,Mycobacterium leprae: genes, pseudogenes and genetic diversity. Future Microbiol 6, 57-71. 2011.
[8]	Schuenemann, V, Avanzi C., Krause-Kyora B., Seitz A., Herbig A, and Inskip S. Ancient genomes reveal a high diversity of Mycobacterium leprae in medieval Europe. PLoS Pathog. 14, e1006997. 2018.
[9]	Coulibaly, N,D, Dehe, B,R, Kakou-N,S, Kouakou,H, Amon, A,C, Sylla, A, Bidie, A, Bamba, V, and Dosso, M, Drugs Susceptibility Testing in Leprosy Patients from Côte d’Ivoire Reveals Multidrugs Resistance Combination Cases to Dapsone, Rifampicin and Ofloxacin.. Am J Microbiol Res, 8(4), 160-163. 2020.
[10]	WHO, A Guide for Antimicrobial Resistance Surveillance in leprosy: update 2017. World Health Organization, Geneva, 56. 2017.
[11]	Yoshikawa, H, Dogruman-Ai, S.Turk F., Kustimur S., and Balaban N, Evaluation of DNA extraction kits for molecular diagnosis of human Blastocystis subtypes from fecal samples. Parasitol Res, 109 (4), 1045-1050. 2011.
[12]	Dehe, B, Coulibaly, N., Kouakou, H, Amon, A,C, Kakou, N, Bamba, V, Bidie, A, and Dosso, M,Comparative assessments of polymerase chain reaction (PCR) assay of repetitive sequence (RLEP) and proline rich antigen (PRA) gene targets for detection of Mycobacterium leprae DNA from paucibacillary (PB) and multibacillary (MB) patients in Côte d’Ivoire (CI). GSCB PS, 11 (01): 085-092. 2020.
[13]	Tió-Coma, M, Wijnands T, Pierneef L, Schilling A.,. Alam K,and Roy J, Detection of Mycobacterium leprae DNA in soil: multiple needles in the haystack. Sci. Rep. 9, 3165. 2019.
[14]	Reibel, F, Chauffour, A., Brossier, F., Jarlier, V., Cambau, E., and Aubry, A. New insights on the geographical distribution of Mycobacterium leprae SNP genotypes determined for isolates of leprosy cases diagnosed in metropolitan France and French territories, PLoS Negl Trop Dis. 9 (10), e0004141. 2015.
[15]	Salipante, S, J, and Hall B, G, Towards the molecular epidemiology of Mycobacterium leprae: strategies, successes and gaps. Infect Genet Evol, 11 (7): 1505-1513. 2011.
[16]	Phetsuksiri, B, Srisungngam, S, Rudeeaneksin, J, Bunchoo, S., Lukebua, A., Wongtrungkapun, R., Paitoon, S, Sakamuri, R,M, Patrick J. Brennan, and Vissa, V, SNP Genotypes of Mycobacterium leprae Isolates in Thailand and Their Combination with rpoT and TTC Genotyping for Analysis of Leprosy Distribution and Transmission. Jpn J Infect Dis 65, 52-56. 2012.
[17]	Benjak, A, Avanzi, C., Singh, P., Loiseau, C., Girma, S.,. Busso, P, Fontes, A., Miyamoto, Y., Namisato, M., Bobosha, K., Salgado, C., Silva, M., Bouth, R., Frade, M., Filho, F., Barreto, J., Nery, J., Bührer-Sékula, S., Lupien, A., Al-Samie, A., and Cole, S; Phylogenomics and antimicrobial resistance of the leprosy bacillus Mycobacterium leprae, Nat Commun 9, 352. 2018.
[18]	Da Silva, R, Alexandre, A., Patrıcia, P., Jose, A., Antonio, B., Diego, F., Amanda, N., Alice, M., Helen, F., Neio, B., Maria, E., Euzenir, N., Maria, L., and Philip, N, S, Genotyping of Mycobacterium leprae from Brazilian leprosy patients suggests reinfection or displacement of the bacterial population recurrence of the disease, J Med Microbiol. 60, 1441-1446. 2011.
[19]	Nery, J, Ramond, A, Pescarini, J., Alves, A., Strina, A., Ichihara, M., Penna, M, Smeeth, L, Rodrigues, L., Barreto, M., Brickley, E., and Penna, G, Socioeconomic determinants of leprosy new case detection in the 100 Million Brazilian Cohort: a population-based linkage study. Lancet Global Health 7, 1226-1236. 2019.